Computational approaches towards the rational design of drug-like compound libraries

被引:1
|
作者
Matter, H [1 ]
Baringhaus, KH [1 ]
Naumann, T [1 ]
Klabunde, T [1 ]
Pirard, B [1 ]
机构
[1] Aventis Pharma Deutschland GmbH, DI&A Chem, Mol Modelling, D-65926 Frankfurt, Germany
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
During the practice of combinatorial chemistry, it has been realized that molecular diversity is not the only essential feature in a synthetically feasible library. In addition, it is of utmost importance to enrich potential libraries with those molecules which could be converted to viable drug candidates. Given the enormous number of potentially synthesizable compounds, there is a need to design a subset of true "drug-like" compounds. In addition, a paradigm shift in drug discovery has resulted in the integration of pharmacokinetic and drug development activities into early stages of lead discovery. In particular, in silico filters are being developed and used to help identify and screen out compounds that are unlikely to become drugs. This paper highlights recent computational approaches towards the design of drug-like compound libraries, in particular, the prediction of drug-likeness in a more general sense as well as intestinal absorption through passive transport, the permeation of the blood-brain barrier and recent developments towards identification of potentially metabolically unstable molecules. Current computational tools for library design allow the incorporation of medicinal chemistry knowledge into library planning by a variety of methods, ranging from the use of privileged building blocks and simple counting of structural properties (e.g. number of hydrogen bonding partners) to relatively complex regression or neural network-based models to explain oral bioavailability and other pharmacokinetic properties by structural features. These tools are being incorporated more frequently into drug design according to the "rule-of-five" which refers to simple descriptors correlated to oral drug absorption. Combining experimental knowledge with effective computational filtering and prediction of various aspects of drug-likeness thus facilitates the rapid and cost-effective elimination of poor candidates prior to synthesis and helps focus attention on interesting molecules.
引用
收藏
页码:453 / 475
页数:23
相关论文
共 50 条
  • [1] Immobilized lead and drug-like compound libraries, a comparative.
    Ürge, L
    Reynolds, D
    Dorman, G
    Puskás, L
    Darvas, F
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U225 - U225
  • [2] Design and evaluation of novel antibody libraries with drug-like specificity
    Desai, Alec
    Starr, Charles
    Pornnoppadol, Ghasidit
    Berg, Brendan
    Tessier, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [3] Drug-like Properties: Guiding Principles for the Design of Natural Product Libraries
    Camp, David
    Davis, Rohan A.
    Campitelli, Marc
    Ebdon, James
    Quinn, Ronald J.
    JOURNAL OF NATURAL PRODUCTS, 2012, 75 (01): : 72 - 81
  • [4] Toward designing drug-like libraries: A novel computational approach for prediction of drug feasibility of compounds
    Wang, J
    Ramnarayan, K
    JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (06): : 524 - 533
  • [5] Structure-based design of focused drug-like combinatorial libraries
    Shenkin, PS
    Frye, LL
    Murphy, RB
    Repasky, MP
    Mainz, DT
    Reboul, M
    Friesner, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1306 - U1307
  • [6] Structure-based design of focused drug-like combinatorial libraries
    Frye, LL
    Murphy, RB
    Reboul, TM
    Shenkin, PS
    Mainz, DT
    Chambers, EW
    McDonald, DQ
    Friesner, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U795 - U796
  • [7] Computational approaches to identify novel drug-like immunomodulators against multiple sclerosis
    Syed, Asif Hassan
    INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2019, 6 (04): : 33 - 44
  • [8] Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein
    Dharra, Renu
    Talwar, Sakshi
    Singh, Yogesh
    Gupta, Rani
    Cirillo, Jeffrey D.
    Pandey, Amit K.
    Kulharia, Mahesh
    Mehta, Promod K.
    PLOS ONE, 2017, 12 (09):
  • [9] Isoliensinine: A Natural Compound with "Drug-Like" Potential
    Cheng, Yan
    Li, Hong-Li
    Zhou, Zi-Wei
    Long, Hui-Zhi
    Luo, Hong-Yu
    Wen, Dan-Dan
    Cheng, Lin
    Gao, Li-Chen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] Towards the discovery of drug-like RNA ligands?
    Foloppe, Nicolas
    Matassova, Natalia
    Aboul-ela, Fareed
    DRUG DISCOVERY TODAY, 2006, 11 (21-22) : 1019 - 1027